|
US4172124A
(en)
|
1978-04-28 |
1979-10-23 |
The Wistar Institute |
Method of producing tumor antibodies
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
|
EP0605522B1
(en)
|
1991-09-23 |
1999-06-23 |
Medical Research Council |
Methods for the production of humanized antibodies
|
|
CA2115811A1
(en)
|
1993-02-17 |
1994-08-18 |
Claus Krebber |
A method for in vivo selection of ligand-binding proteins
|
|
US5919661A
(en)
|
1997-08-25 |
1999-07-06 |
Incyte Pharmaceuticals, Inc. |
Polynucleotides encoding cytokine inducible regulatory protein
|
|
JPH11199507A
(ja)
|
1998-01-09 |
1999-07-27 |
Chugai Pharmaceut Co Ltd |
脳疾患及び神経疾患治療薬
|
|
WO2001009387A1
(en)
|
1999-07-29 |
2001-02-08 |
Northeastern University |
Isolation of novel hemapoietic genes by representational difference analysis
|
|
US6610713B2
(en)
|
2000-05-23 |
2003-08-26 |
North Shore - Long Island Jewish Research Institute |
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
|
|
US7317077B2
(en)
|
2001-11-16 |
2008-01-08 |
Nymox Pharmaceutical Corporation |
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
|
|
BRPI0511272A
(pt)
|
2004-05-17 |
2007-12-04 |
Combinatorx Inc |
métodos e reagentes para o tratamento de distúrbios imunoinflamatórios
|
|
CA2675954A1
(en)
*
|
2007-01-18 |
2008-07-24 |
Plant Bioscience Limited (Pbl) |
Methods and compositions for modulating the mirna pathway
|
|
WO2009090287A1
(es)
*
|
2008-01-17 |
2009-07-23 |
Fundació Institut de Recerca de L'Hospital Universitari Vall d'Hebron |
Compuestos antitumorales basados en cirp
|
|
US11607391B2
(en)
*
|
2008-09-25 |
2023-03-21 |
Trs Holdings Llc |
Mineral-coated microspheres
|
|
WO2010120726A1
(en)
*
|
2009-04-13 |
2010-10-21 |
The Feinstein Institute For Medical Research |
Treatment of inflammatory diseases by inhibiting cold- inducible rna-binding protein (cirp)
|
|
US20140193412A1
(en)
|
2013-01-10 |
2014-07-10 |
The Feinstein Institute For Medical Research |
Treatment of cutaneous wounds by inhibiting cold shock proteins
|
|
WO2015048083A1
(en)
|
2013-09-24 |
2015-04-02 |
The Feinstein Institute For Medical Research |
Peptides inhibiting cold-inducible rna binding protein activity
|